Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β by Úrsula Muñoz, Cristina Sebal, Esther Escudero, Elena Urcelay, Rafael Arroyo, Maria A. García-Martínez, Francisco J. Quintana, Roberto Álvarez-Lafuente, Maria Cruz Sádaba

Get full text